About Avinger (NASDAQ:AVGR)
Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The Company focuses on introducing products based on its lumivascular platform, which is an intravascular image-guided system. The Company manufactures and sells a suite of products in the United States and certain European markets. The Company's products include Lightbox imaging console, as well as its Wildcat, Kittycat and the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO). The lumivascular platform offers real-time visualization of the inside of the artery during PAD treatment. The lumivascular platform consists of a capital component Lightbox and a range of disposable catheter products, including Ocelot, Ocelot PIXL, Ocelot MVRX and Pantheris.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Imaging Systems
- Sub-Industry: N/A
- Symbol: NASDAQ:AVGR
- CUSIP: N/A
- Web: www.avinger.com
Capitalization:- Market Cap: $7.54 million
- Outstanding Shares: 23,914,000
Average Prices:- 50 Day Moving Avg: $0.31
- 200 Day Moving Avg: $0.31
- 52 Week Range: $0.21 - $4.89
P/E:- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -0.51
- P/E Growth: 0.00
Sales & Book Value:- Annual Revenue: $15.94 million
- Price / Sales: 0.53
- Book Value: ($0.87) per share
- Price / Book: -0.40
Profitability:- EBITDA: ($46,300,000.00)
- Net Margins: -342.46%
- Return on Assets: -119.80%
Debt:- Current Ratio: 0.49%
- Quick Ratio: 0.35%
Misc:- Average Volume: 2.98 million shs.
- Beta: -0.03
- Short Ratio: 0.97
Frequently Asked Questions for Avinger (NASDAQ:AVGR)
What is Avinger's stock symbol?
Avinger trades on the NASDAQ under the ticker symbol "AVGR."
How were Avinger's earnings last quarter?
Avinger, Inc. (NASDAQ:AVGR) announced its quarterly earnings data on Monday, August, 1st. The company reported ($1.06) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($1.15) by $0.09. The company had revenue of $4.70 million for the quarter, compared to the consensus estimate of $3.05 million. View Avinger's Earnings History.
When will Avinger make its next earnings announcement?
Where is Avinger's stock going? Where will Avinger's stock price be in 2017?
4 brokerages have issued 1-year target prices for Avinger's stock. Their predictions range from $5.00 to $5.00. On average, they expect Avinger's share price to reach $5.00 in the next twelve months. View Analyst Ratings for Avinger.
Who are some of Avinger's key competitors?
Some companies that are related to Avinger include Galena Biopharma (GALE), Transgenomic (PRPO), RXi Pharmaceuticals Corporation (RXII), CRITICAL OUTCOME T COM NPV(POST REV SPLIT) (COTQF), Novogen Limited (NVGN), Valeritas Holdings (VLRX), Opexa Therapeutics (ACER), Tandem Diabetes Care (TNDM), Immune Pharmaceuticals (IMNP), Jaguar Animal Health (JAGX), Lombard Medical (EVAR), Dynatronics Corporation (DYNT), Kitov Pharmaceuticals Holdings (KTOV), Argos Therapeutics (ARGS), Relmada Therapeutics (RLMDD), Roka Bioscience (ROKA), Acura Pharmaceuticals (ACUR) and ESSA Pharma (EPIX).
Who are Avinger's key executives?
Avinger's management team includes the folowing people:
- John B. Simpson M.D. Ph.D., Executive Chairman of the Board
- Jeffrey M. Soinski, President, Chief Executive Officer, Director
- Matthew B. Ferguson, Chief Business Officer and Chief Financial Officer
- Sougata Banerjee, Senior Vice President - Operations and Quality
- Himanshu N. Patel, Chief Technology Officer
- Philip R. Preuss, Vice President - Marketing and Business Operations
- James G. Cullen, Independent Director
- Thomas J. Fogarty M.D., Independent Director
- Donald A. Lucas Jr., Independent Director
- James B. McElwee, Independent Director
When did Avinger IPO?
(AVGR) raised $60 million in an IPO on Friday, January 30th 2015. The company issued 4,600,000 shares at a price of $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company served as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers.
How do I buy Avinger stock?
Shares of Avinger can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Avinger's stock price today?
One share of Avinger stock can currently be purchased for approximately $0.35.
MarketBeat Community Rating for Avinger (NASDAQ AVGR)MarketBeat's community ratings are surveys of what our community members think about Avinger and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Avinger (NASDAQ:AVGR) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 3 Hold Ratings, 1 Buy Rating |
| Consensus Rating: | Hold (Score: 2.25) |
| Consensus Price Target: | $5.00 (1,328.57% upside) |
Consensus Price Target History for Avinger (NASDAQ:AVGR)
Analysts' Ratings History for Avinger (NASDAQ:AVGR)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 4/14/2017 | Cowen and Company | Reiterated Rating | Buy | | N/A |  |
| 4/12/2017 | CIBC | Downgrade | Outperform -> Market Perform | | High | |
| 4/12/2017 | Oppenheimer Holdings, Inc. | Reiterated Rating | Outperform -> Market Perform | | High | |
| 4/11/2017 | Canaccord Genuity | Downgrade | Buy -> Hold | | High | |
| 8/15/2016 | BTIG Research | Reiterated Rating | Buy | $18.00 -> $6.00 | N/A | |
| 1/4/2016 | Dougherty & Co | Downgrade | Buy -> Hold | | N/A | |
(Data available from 10/21/2015 forward)
Earnings History for Avinger (NASDAQ:AVGR)Earnings History by Quarter for Avinger (NASDAQ AVGR)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 11/1/2017 | | ($0.37) | | | | | N/A | |
| 3/6/2017 | Q4 2016 | ($0.55) | ($0.58) | $4.70 million | $4.68 million | View | Listen | |
| 11/3/2016 | Q3 | ($0.84) | ($0.73) | $4.90 million | $5.30 million | View | N/A | |
| 8/1/2016 | Q2 | ($1.15) | ($1.06) | $3.05 million | $4.70 million | View | Listen | |
| 5/4/2016 | Q1 | ($1.17) | ($1.28) | $2.90 million | $4.54 million | View | Listen | |
| 3/1/2016 | Q4 | ($1.04) | ($1.07) | $3.10 million | $2.86 million | View | Listen | |
| 11/5/2015 | Q315 | ($0.88) | ($1.08) | $3.10 million | $2.70 million | View | Listen | |
| 7/28/2015 | Q215 | ($1.16) | ($0.83) | $2.72 million | $3.00 million | View | Listen | |
| 5/6/2015 | Q1 | ($1.15) | ($1.53) | $2.30 million | $2.09 million | View | Listen | |
| 3/12/2015 | Q414 | ($0.75) | ($33.62) | $3.10 million | $3.07 million | View | Listen | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Avinger (NASDAQ:AVGR)2017 EPS Consensus Estimate: ($1.94)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 1 | ($0.73) | ($0.73) | ($0.73) |
| Q2 2017 | 1 | ($0.46) | ($0.46) | ($0.46) |
| Q3 2017 | 1 | ($0.38) | ($0.38) | ($0.38) |
| Q4 2017 | 1 | ($0.37) | ($0.37) | ($0.37) |
(Data provided by Zacks Investment Research)
Dividend History for Avinger (NASDAQ:AVGR)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Avinger (NASDAQ:AVGR)Insider Ownership Percentage: 17.00%
Institutional Ownership Percentage: 15.37%
Insider Trades by Quarter for Avinger (NASDAQ:AVGR)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 8/16/2016 | Jeffrey M Soinski | CEO | Buy | 57,100 | $3.50 | $199,850.00 | |
| 8/16/2016 | Matthew Ferguson | CFO | Buy | 7,000 | $3.50 | $24,500.00 | |
| 5/6/2016 | Donald A Lucas | Director | Sell | 9,309 | $12.58 | $117,107.22 | |
| 5/6/2016 | Himanshu Patel | Insider | Sell | 10,000 | $13.40 | $134,000.00 | |
| 4/15/2016 | John B Ph D Md Simpson | Major Shareholder | Sell | 75,111 | $13.11 | $984,705.21 | |
| 3/11/2016 | John B Ph D Md Simpson | Major Shareholder | Sell | 40,000 | $11.44 | $457,600.00 | |
| 3/11/2016 | Matthew Ferguson | CFO | Buy | 1,500 | $11.37 | $17,055.00 | |
| 12/14/2015 | Donald A Lucas | Director | Sell | 2,500 | $16.22 | $40,550.00 | |
| 12/11/2015 | Donald A Lucas | Director | Sell | 4,000 | $15.92 | $63,680.00 | |
| 11/25/2015 | John B Ph D Md Simpson | Major Shareholder | Sell | 100,000 | $17.26 | $1,726,000.00 | |
| 11/24/2015 | John B Ph D Md Simpson | Chairman | Sell | 42,445 | $17.20 | $730,054.00 | |
| 2/4/2015 | Himanshu Patel | CTO | Sell | 1,731 | $13.00 | $22,503.00 | |
| 2/4/2015 | James Cullen | Director | Sell | 2,307 | $13.00 | $29,991.00 | |
| 2/4/2015 | Matthew Ferguson | CFO | Sell | 1,154 | $13.00 | $15,002.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Avinger (NASDAQ:AVGR)
Latest Headlines for Avinger (NASDAQ:AVGR)
| Source: |
|
| Date | Headline |
|---|
 | Avinger Announces First Patient Enrolled in its IDE Study of the Pantheris Image-Guided Atherectomy System for Treatment of In-Stent Restenosis
finance.yahoo.com - October 19 at 4:46 PM |
| Edited Transcript of AVGR earnings conference call or presentation 4-May-17 8:30pm GMT
finance.yahoo.com - October 17 at 5:04 PM |
| ETFs with exposure to Avinger, Inc. : October 11, 2017
finance.yahoo.com - October 11 at 5:45 PM |
| Avinger Receives CE Marking Approval for In-Stent Restenosis Treatment Indication With Pantheris Image-Guided Atherectomy
finance.yahoo.com - October 2 at 4:10 PM |
| ETFs with exposure to Avinger, Inc. : September 28, 2017
finance.yahoo.com - October 2 at 4:10 PM |
 | CE Mark Sparks Avinger, Shares Soar 130%
www.baystreet.ca - September 28 at 9:38 PM |
| FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Avinger, Inc. (AVGR) and Lead Plaintiff Deadline: September 5, 2017
finance.yahoo.com - September 5 at 5:50 PM |
 | INVESTOR ALERT: Goldberg Law PC Announces a Securities Class Action Lawsuit against Avinger, Inc.
feeds.benzinga.com - September 2 at 12:39 AM |
| Scott+Scott, Attorneys at Law, LLP Reminds Investors of Upcoming September 5th Deadline for Lead Plaintiff Motions in Securities Class Action Against Avinger, Inc. (AVGR)
finance.yahoo.com - August 30 at 5:29 PM |
| 6-DAY DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Avinger, Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 30 at 5:29 PM |
| INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Avinger, Inc. (AVGR) and Lead Plaintiff Deadline: September 5, 2017
finance.yahoo.com - August 29 at 4:32 PM |
| UPCOMING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Avinger, Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 29 at 4:32 PM |
| ETFs with exposure to Avinger, Inc. : August 25, 2017
finance.yahoo.com - August 25 at 5:50 PM |
| IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Avinger, Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 24 at 9:17 PM |
| DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Avinger, Inc. (AVGR) and Lead Plaintiff Deadline: September 5, 2017
finance.yahoo.com - August 24 at 4:13 PM |
| APPROACHING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Avinger, Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 23 at 4:18 PM |
| EQUITY ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against Avinger, Inc.
finance.yahoo.com - August 22 at 9:56 PM |
| AVINGER LOSS NOTICE: Rosen Law Firm Reminds Avinger, Inc. Investors of Important Deadline in Class Action
finance.yahoo.com - August 22 at 4:56 PM |
| AVGR Investors Deadline Reminder: Hagens Berman Reminds Investors in Avinger, Inc. of the September 5, 2017 Lead Plaintiff Deadline in the Pending Securities Class Action
finance.yahoo.com - August 22 at 4:56 PM |
| Avinger, Inc. :AVGR-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017
finance.yahoo.com - August 16 at 4:47 PM |
| EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Avinger, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - August 14 at 9:38 PM |
 | Avinger, Inc. (NASDAQ:AVGR) Short Interest Update
www.americanbankingnews.com - August 13 at 2:20 AM |
| IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Avinger, Inc. and Reminds Investors with Losses to Contact the Firm
feeds.benzinga.com - August 12 at 1:31 AM |
| Scott+Scott, Attorneys at Law, LLP Announces Deadline for Lead Plaintiff Motions in Federal Securities Case Against Avinger, Inc. (NASDAQ: AVGR)
finance.yahoo.com - August 10 at 3:55 PM |
 | Avinger's (AVGR) CEO Jeff Soinski on Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - August 9 at 9:28 PM |
| Edited Transcript of AVGR earnings conference call or presentation 8-Aug-17 8:30pm GMT
finance.yahoo.com - August 9 at 4:26 PM |
| Avinger reports 2Q loss
finance.yahoo.com - August 9 at 4:26 PM |
| Avinger Announces Second Quarter 2017 Results
finance.yahoo.com - August 8 at 9:05 PM |
| Avinger Announces Participation in Canaccord Genuity 37th Annual Growth Conference
finance.yahoo.com - August 3 at 5:38 PM |
| Scott+Scott, Attorneys at Law, LLP Announces Deadline for Lead Plaintiff Motions in Federal Securities Case Against Avinger, Inc. (AVGR)
finance.yahoo.com - August 1 at 5:10 PM |
| Avinger, Inc. (AVGR) to Release Earnings on Tuesday
www.americanbankingnews.com - August 1 at 7:31 AM |
| Critical Review: EndoChoice Holdings (GI) versus Avinger (AVGR)
www.americanbankingnews.com - July 26 at 8:28 PM |
| SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Avinger, Inc. (AVGR) & Lead Plaintiff Deadline: September 5, 2017
finance.yahoo.com - July 26 at 4:51 PM |
| Avinger to Announce Second Quarter 2017 Results on August 8, 2017
finance.yahoo.com - July 26 at 4:51 PM |
| Avinger, Inc. (AVGR) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - July 25 at 6:45 PM |
| Reviewing Analogic Corporation (ALOG) and Avinger (NASDAQ:AVGR)
www.americanbankingnews.com - July 25 at 6:12 PM |
| AVGR Investors Update: Hagens Berman Updates Investors in Avinger, Inc. Concerning Securities Class Action Pending in Federal Court and Reminds Them of the September 5, 2017 Lead Plaintiff Deadline
finance.yahoo.com - July 25 at 4:08 PM |
| Avinger, Inc. (AVGR) to Release Quarterly Earnings on Monday
www.americanbankingnews.com - July 24 at 7:56 AM |
| Avinger, Inc. (NASDAQ:AVGR) Sees Large Decline in Short Interest
www.americanbankingnews.com - July 17 at 7:18 AM |
| Haeggquist & Eck, LLP Announces Investigation of Potential Corporate Misconduct at Avinger, Inc. in Connection with Its IPO and the Sales and Safety of the Company’s Products
finance.yahoo.com - July 14 at 6:05 PM |
| Analyzing EndoChoice Holdings (GI) & Avinger (NASDAQ:AVGR)
www.americanbankingnews.com - July 14 at 8:36 AM |
| AVGR SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Securities Action Involving Avinger, Inc. (AVGR)
finance.yahoo.com - July 13 at 4:59 PM |
| Robbins Arroyo LLP: Avinger, Inc. (AVGR) Misled Shareholders According to a Class Action
finance.yahoo.com - July 13 at 2:30 AM |
| Bottini & Bottini, Inc. Files Securities Class-Action Lawsuit Against Avinger, Inc.
finance.yahoo.com - July 8 at 8:59 PM |
| INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of Commencement of a Securities Action on Behalf of Shareholders of Avinger, Inc. - AVGR
finance.yahoo.com - July 8 at 8:59 PM |
| SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Avinger, Inc. (AVGR) & Lead Plaintiff Deadline: September 5, 2017
finance.yahoo.com - July 8 at 8:59 PM |
| INVESTOR ALERT: Khang & Khang LLP Announces...
www.benzinga.com - July 8 at 7:27 AM |
| INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Avinger, Inc. and Encourages Investors with Losses to Contact the Firm
feeds.benzinga.com - July 8 at 1:53 AM |
| Head-To-Head Comparison: Avinger (AVGR) and EndoChoice Holdings (GI)
www.americanbankingnews.com - July 5 at 8:30 PM |
| The Klein Law Firm Notifies Investors of a Securities Action Filed on Behalf of Avinger, Inc. Shareholders (AVGR)
feeds.benzinga.com - June 12 at 12:43 PM |
Avinger (AVGR) Chart for Saturday, October, 21, 2017
